Biomarkers, C-reactive proteins and statins in acute coronary syndromesRAY, Kausik K.Fundamental & clinical pharmacology. 2007, Vol 21, pp 31-33, issn 0767-3981, 3 p., SUP2Conference Paper

The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes : Prove IT-TIMI 22RAY, Kausik K; CANNON, Christopher P.Journal of the American College of Cardiology. 2005, Vol 46, Num 8, pp 1425-1433, issn 0735-1097, 9 p.Article

High-Density Lipoprotein and Coronary Heart Disease: Current and Future Therapies : Prevention/outcomesNATARAJAN, Pradeep; RAY, Kausik K; CANNON, Christopher P et al.Journal of the American College of Cardiology. 2010, Vol 55, Num 13, pp 1283-1299, issn 0735-1097, 17 p.Article

Beyond lipid lowering : What have we learned about the benefits of statins from the acute coronary syndromes trials?RAY, Kausik K; CANNON, Christopher P; GANZ, Peter et al.The American journal of cardiology. 2006, Vol 98, Num 11, issn 0002-9149, 18P-25P, SUPArticle

Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22)RAY, Kausik K; MORROW, David A; SHUI, Amy et al.The American journal of cardiology. 2006, Vol 98, Num 7, pp 861-865, issn 0002-9149, 5 p.Article

Early time to benefit with intensive statin treatment : Could it be the pleiotropic effects?RAY, Kausik K; CANNON, Christopher P.The American journal of cardiology. 2005, Vol 96, Num 5, pp 54F-60F, issn 0002-9149, SUPConference Paper

C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial)MOGHBELI, Nazanin; KIRTANE, Ajay J; RAY, Kausik K et al.The American journal of cardiology. 2005, Vol 96, Num 5, pp 635-638, issn 0002-9149, 4 p.Article

Predictors of the rise in vWF after ST elevation myocardial infarction : implications for treatment strategies and clinical outcome : An ENTIRE-TIMI 23 substudyRAY, Kausik K; MORROW, David A; GIBSON, C. Michael et al.European heart journal. 2005, Vol 26, Num 5, pp 440-446, issn 0195-668X, 7 p.Article

Genetic variation at the interleukin-I locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromesRAY, Kausik K; CAMP, Nicola J; BENNETT, Claire E et al.Clinical science (1979). 2002, Vol 103, Num 3, pp 303-310, issn 0143-5221, 8 p.Article

The effects of statins on blood pressure in normotensive or hypertensive subjects — A meta-analysis of randomized controlled trialsBANACH, Maciej; NIKFAR, Shekoufeh; RAHIMI, Roja et al.International journal of cardiology. 2013, Vol 168, Num 3, pp 2816-2824, issn 0167-5273, 9 p.Article

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP―GPRD)BOGGON, Rachael; VAN STAA, Tjeerd P; TIMMIS, Adam et al.European heart journal. 2011, Vol 32, Num 19, pp 2376-2386, issn 0195-668X, 11 p.Article

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy : A PROVE IT-TIMI 22 substudy : Prove IT-TIMI 22WIVIOTT, Stephen D; CANNON, Christopher P; MORROW, David A et al.Journal of the American College of Cardiology. 2005, Vol 46, Num 8, pp 1411-1416, issn 0735-1097, 6 p.Article

Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes : Results From PROVE IT-TIMI 22RAY, Kausik K; CANNON, Christopher P; CAIRNS, Richard et al.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 3, pp 424-430, issn 1079-5642, 7 p.Article

Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trialBHADRIRAJU, Satish; RAY, Kausik K; BRAUNWALD, Eugene et al.The American journal of cardiology. 2006, Vol 97, Num 11, pp 1573-1577, issn 0002-9149, 5 p.Article

Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACSRAY, Kausik K; BACH, Richard G; CANNON, Christopher P et al.European heart journal. 2006, Vol 27, Num 19, pp 2310-2316, issn 0195-668X, 7 p.Article

Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration ratesKIRTANE, Ajay J; LEDER, David M; BRAUNWALD, Eugene et al.Journal of the American College of Cardiology. 2005, Vol 45, Num 11, pp 1781-1786, issn 0735-1097, 6 p.Article

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)WILSON, Sean R; SABATINE, Marc S; WIVIOTT, Stephen D et al.The American heart journal. 2011, Vol 161, Num 6, pp 1147-1155, issn 0002-8703, 9 p.Article

B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective StudiesDI ANGELANTONIO, Emanuele; CHOWDHURY, Rajiv; SARWAR, Nadeem et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 22, pp 2177-2187, issn 0009-7322, 11 p.Article

Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes : analyses from OPUS-TIMI 16 and TACTICS-TIMI 18RAY, Kausik K; CANNON, Christopher P; MORROW, David A et al.European heart journal. 2007, Vol 28, Num 7, pp 806-813, issn 0195-668X, 8 p.Article

Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndromeGIBSON, C. Michael; KARMPALIOTIS, Dimitri; FRENCH, William et al.The American journal of cardiology. 2006, Vol 97, Num 10, pp 1473-1477, issn 0002-9149, 5 p.Article

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial : Prove IT-TIMI 22RAY, Kausik K; CANNON, Christopher P; BRAUNWALD, Eugene et al.Journal of the American College of Cardiology. 2005, Vol 46, Num 8, pp 1417-1424, issn 0735-1097, 8 p.Article

A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?NIKOLIC, Dragana; BANACH, Maciej; RYSZ, Jacek et al.International journal of cardiology. 2013, Vol 168, Num 6, pp 5437-5447, issn 0167-5273, 11 p.Article

Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trialsNIKOLIC, Dragana; NIKFAR, Shekoufeh; ABDOLLAHI, Mohammad et al.Current medical research and opinion. 2013, Vol 29, Num 5, pp 435-451, issn 0300-7995, 17 p.Article

Omega-3 Fatty Acids and Mortality Outcome in Patients With and Without Type 2 Diabetes After Myocardial Infarction: A Retrospective, Matched-Cohort StudyPOOLE, Chris D; HALCOX, Julian P; JENKINS-JONES, Sara et al.Clinical therapeutics. 2013, Vol 35, Num 1, pp 40-51, issn 0149-2918, 12 p.Article

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusSCIRICA, Benjamin M; BHATT, Deepak L; CAVENDER, Matthew A et al.The New England journal of medicine. 2013, Vol 369, Num 14, pp 1317-1326, issn 0028-4793, 10 p.Article